Articles

COVID-19's Impact: Help Ensure  Quality and Manage Risk 

This whitepaper will cover five areas for consideration by oncology drug developers & the potential solutions in development, manufacturing & supply that are emerging.

Accelerating the Development of Oncology Medicines

Engineering Approaches to Respiratory Drug Delivery: Case Study on Mannitol

Container Closure Integrity and Deep Cold Storage

Early Drug Development Strategies for Clinical Success

Specialized Services for Complex Clinical Studies

This white paper addresses the principal CMC challenges for the developers of orphan drugs and highlights the potential solutions which are emerging.


Accelerating the Development of Orphan Drugs for Rare Diseases

The aim of this study was to investigate the influence of different commonly used lubricant and disinterants on tablet surface and film coating adhesion.

Formulation Effects on Tablet Surface Properties and Film Coating Adhesion

Detection of N-Nitrosodimethylamine (NDMA) impurities has led to regulatory warnings and product recalls. Pharmaceutical manufacturers must adopt a proactive approach to risk assessment and mitigation in relation to genotoxic contaminants.

Nitrosamine Testing: The Regulatory Aspects

This white paper details how to unlock value with product inspection.


Industry 4.0 Guide

Analytics Whitepapers

Drug Delivery Whitepapers

Excipients Whitepapers

Formulation Whitepapers

IT Whitepapers

Ingredients Whitepapers

Manufacturing Whitepapers

Outsourcing Whitepapers

Packaging & Labeling Whitepapers

Regulatory Whitepapers

Whitepapers

All Whitepapers